• Office-B, 2nd Floor, C-70, DDA Sheds, Okhla Industrial Estate, Phase-1, New Delhi-110020, India
  • +91 9818788725
  • unimedntech@yahoo.com

GALCANEZUMAB

GALCANEZUMAB

Injection

EMGALITY (galcanezumab-gnlm) injection, for subcutaneous use. EMGALITY® is a calcitonin-gene related peptide Antagonist indicated in adults for the • preventive treatment of migraine. • treatment of episodic cluster headache.
"• Injection: 120 mg/mL solution in a single-dose prefilled pen (3) • Injection: 120 mg/mL solution in a single-dose prefilled syringe (3) • Injection: 100 mg/mL solution in a single-dose prefilled syringe"
"• For subcutaneous use only. • Migraine recommended dosage: 240 mg loading dose (administered as two consecutive injections of 120 mg each), followed by monthly doses of 120 mg. • Episodic cluster headache recommended dosage: 300 mg (administered as three consecutive injections of 100 mg each) at the onset of the cluster period, and then monthly until the end of the cluster period. • Administer in the abdomen, thigh, back of the upper arm, or buttocks subcutaneously."
• Migraine • Episodic cluster headache